Difference between revisions of "CART-EGFRvIII"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== T cells redirected to the epidermal growth factor receptor variant III (EGFRvIII) mutation by a chimeric antigen receptor (CAR) Category:Chimeric an...") |
m |
||
| Line 2: | Line 2: | ||
T cells redirected to the epidermal growth factor receptor variant III (EGFRvIII) mutation by a chimeric antigen receptor (CAR) | T cells redirected to the epidermal growth factor receptor variant III (EGFRvIII) mutation by a chimeric antigen receptor (CAR) | ||
| − | [[Category: | + | [[Category:Anti-EGFRvIII CAR T-cells]] |
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Glioblastoma medications (investigational)]] | [[Category:Glioblastoma medications (investigational)]] | ||
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
[[Category:Stub]] | [[Category:Stub]] | ||
Latest revision as of 15:33, 28 June 2023
Mechanism of action
T cells redirected to the epidermal growth factor receptor variant III (EGFRvIII) mutation by a chimeric antigen receptor (CAR)